Vaginal Health

is an important part of a woman's overall wellbeing

CFReSHC CF-SRH Resource Guide by Patients for Providers and Patients

 

Introduction 

Vaginal symptoms can negatively impact fertility, intimate relationships (desire for sex and ability to reach orgasm) and self-confidence.

Researchers indicate that women with CF suffer from multiple vaginal issues. For example, 18% of women with CF report that they experience yeast infections due to frequent antibiotic use for pulmonary exacerbations [1]. A 2001 study in Verona, Italy surveyed 94 CF patients who had received antibiotic therapy in the last year, finding that 61% of the women reported vulvo-vaginal disorders [2]. A French study reported in 2015 that CF patients receiving antibiotic therapy had a “higher incidence of vulvovaginal disorders,” which could be due to the antibiotics destroying protective bacteria in the vagina [3].

Further, women in the US with CF have reported having thick cervical mucus, which is due to abnormal CFTR function [4]. Thick cervical mucus can make routine pelvic exams painful and can impede fertilization by blocking sperm and/or increasing the amount of time it takes to become pregnant [4]. [see (In)Fertility chapter] Women with CF also experience intimacy issues such as “pain during sex….coughing during sex, excessive flatulence, and coughing up blood during or after sex” [1]. Moreover, Chambers et al found higher rates of dyspareunia and coital incontinence in the CF population than in the general population [5]. 

Appropriate management of such symptoms is lacking as well. In the French study, for instance, researchers examined whether adult female participants (n=120) received adequate gynecological management, finding that: “gynaecological care (frequency of follow-up, cervical screening and contraceptive use among sexually active women) in women with CF fails to reach the recommended level” [6].

Priority Questions on Vaginal Health for Providers and Patients to ask during a Clinic Visit

  • Do you have a gynecologist that you see regularly who manages your vaginal health, such as screening for sexually transmitted infections?
  • Have you noticed any changes to your vaginal health or menstrual cycle since starting modulators?
  • Do you ever have issues with yeast infections or other vaginal infections?
    • What do you do when you have symptoms of a vaginal yeast infection? Are you worried about vaginal yeast infection due to antibiotic use? If so, we should discuss treatment options as antifungals may not be an option due to modulator use.

To Any Provider

  • Report any vaginal health issues to your PCP or CF Clinic Provider.

Patient to CF Providers: 

  • I’m noticing vaginal changes since starting a modulator. Is this to be expected/a common side effect?

Patient to OB/GYNs

  • I have painful sex and it seems that I have vaginal dryness and/or vaginal tightness. Is there a way you can help me to address and manage these symptoms?
  • What does my cervical mucus look like now? Is it different from my prior visit?
  • A request: My cervical surface is fragile, please be careful if you have to scrape off cervical mucus for this pelvic exam.

Terminology

Understanding vaginal health terminology is key to seeking proper diagnosis and treatment. 

VAGINITIS: defined as vaginal inflammation that can result in discharge, itching and pain.

Common types of vaginitis are:

  • Bacterial Vaginosis: see Causes, Symptoms and Treatment chart 
  • Yeast Infections: see Causes, Symptoms and Treatment chart 
  • Trichomoniasis: Caused by a parasite commonly transmitted by sexual intercourse.
  • Viral Vaginosis: Viruses of the vagina mostly spread through sexual contact.

VAGINISMUS: A condition in which involuntary muscle spasms prevent vaginal penetration.

VAGINAL ATROPHY:  A condition in which the lining of the vagina becomes thinner and drier. Vaginal dryness can be caused by a drop in estrogen levels as a result of menopause, childbirth, or ovary removal. Cervical mucus can be affected by vaginal dryness, antibiotics and transplant medication. Further research is underway to understand the impact of CF modulators on cervical mucus.

VULVODYNIA: Chronic pain or discomfort around the opening of the vagina.

Researchers are trying to find the causes of vulvodynia [7]. They may include:

POSSIBLE CAUSES OF VULVODYNIA
Allergies or irritation to chemicals or other substances Abnormal response in vulvar cells to an infection or trauma Genetic factors that make the vulva respond poorly to a chronic inflammation Hypersensitivity to yeast infections
Muscle spasms Nerve injury or irritation Hormonal changes History of sexual abuse
Frequent antibiotic abuse Weakness of the pelvic floor muscles Irritation from Candida (yeast) which can cause an area around the vulva to be very sensitive

VAGINAL CANCER: A disease in which malignant (cancer) cells form in the vagina. Signs and symptoms include pain and abnormal vaginal bleeding. Pap smear tests can detect cancer. The HPV vaccine is an effective prevention.

VULVAR CANCER: A type of cancer that occurs on the outer surface area of the female genitalia. It commonly occurs as a lump or sore on the vulva that often causes itching. HPV vaccination also prevents vulvar cancer.

SEXUALLY TRANSMITTED INFECTIONS (STI): These infections spread through sexual contact, including intercourse, and require testing by a gynecologist or primary care provider. STIs, such as herpes, can negatively impact vaginal health, potential pregnancy, and sexual partners. Self monitoring can help a woman with CF notice and address potential symptoms with their women’s health provider. Symptoms to report include:

What to know about Vaginal Infections 

While the symptoms of bacterial vaginosis (BV) and vaginal yeast infections (VYI) seem similar, there is a difference between these two diagnoses. BV is an imbalance of bacteria that is associated with an increased risk of getting HIV, pelvic inflammatory disease and adverse pregnancy outcomes [8]. VYI are more common due to antibiotic use breaking down healthy bacteria within the body. [See chart for causes, symptoms and treatment for VYI and BV]

While CF clinics may prescribe antifungal remedies while a patient is on antibiotics, clinicians may overlook other conditions, such as BV and sexually transmitted infections (STIs), because diagnosis requires pelvic exams and/or specialized testing [9, 10]. Yet the latter testing may be necessary, not least of which because women with CF can have multiple infections at the same time. Baldwin believes that additional research is needed to better understand the incidence of bacterial vaginosis (BV) and vaginal yeast infections (VYI) in the female CF population [9]. 

There is a dearth of extant scientific literature about STIs in cystic fibrosis (CF). Unfortunately, human papillomavirus (HPV) infection has a very high prevalence rate worldwide, with over 80% of sexually active adults infected at some point in their life, and is a well-known, necessary (but insufficient) cause for cervical cencer [11, 12]. For its part, herpes simplex virus (HSV) is another very common STI; because of the physical and psychological morbidities associated with it, women with CF should take precautions to prevent its acquisition [13]. These common infections likely impact the lives of sexually active members of the CF community. While women with CF might not want to seek additional specialty care, Dr. Baldwin encourages routine gynecological care to ensure proper diagnostic testing.

CAUSES, SYMPTOMS AND TREATMENT FOR VYI AND BV
Vaginal Yeast Infections (VYI) Bacterial Vaginosis (BV)
Causes Overgrowth of Candida fungus possibly due to: high blood sugar, antibiotics, pregnancy, birth control pills, hormone replacement therapy Change in the vaginal pH

e.g. Gardnerella vaginalis bacteria

Symptoms
  • Redness and swelling around the vaginal opening
  • Thick, white, “cottage cheese-like” vaginal discharge
  • Pain, soreness, and itching of the vulva
  • Burning sensation when urinating
  • Burning sensation during intercourse
  • “Fishy” ordor that gets stronger after sex or during menstration
  • Thin vaginal discharge (gray, yellow or greenish in color.)
  • Vaginal itching
  • Burning during urination
Treatments Prescribed and over the counter (OTC) medications such as miconazole, monistat or fluconazole. Always requires prescription medications such as metronidazole, tinidazole and clindamycin.

A CFReSHC snap poll revealed that 22 of 61 respondents use an antifungal (oral or vaginal cream) routinely or as needed to treat their VYI. Twenty-nine respondents preferred an OTC treatment; 10 used other options such as modifying their diet or using homeopathic treatments [14].

Research on Vaginal Health

Kazmerski’s survey on sexual and reproductive health among 188 adolescent girls and young adult women with CF found in 2018 that 18% experienced yeast infections and that only 26% had ever undergone a Pap smear or pelvic exam (unlike 57% of women without CF) [1].

A CFReSHC Snap poll (n=80) on the topic of vaginal health indicated that 48.1% of respondents experienced vaginal yeast infections. Yet, sexual and fertility issues are rarely talked about during routine CF clinic visits. Since women with CF are now identifying sexual and reproductive concerns as important to them, it is important to address such symptoms and conditions. Experiencing issues such as recurrent vaginal candidiasis, thick cervical mucus, dyspareunia, and vaginal dryness can lead to depression, feeling less satisfied with life, poorer self esteem, and increased stress levels which can then interfere with sexual and emotional relationships [1, 15].

As you age, so does your vagina  

In October 2016, Healthline writer Annette McDermott described how the vagina is a complex organ that plays a role in sexual pleasure and childbirth. She writes  that as you age, your vagina will too [13].

There is a variety of information available about vaginal health and aging, including: 

  • Estrogen is responsible for keeping the vagina lubricated, elastic, and acidic. 
  • The vagina is designed to be self-cleaning but women may have a normal white or clear discharge. 
  • Hormonal changes during a woman’s menstrual cycle affect the amount and type of discharge her/their vagina produces. 
  • Unless a woman is having symptoms– such as pain during sex, itching, a foul-smelling discharge, or burning— her vagina needs little maintenance other than daily washing with mild soap and water. 
  • After a vaginal birth, the vagina may lose some of its elasticity and stretch more than usual but over time, most vaginas will return to almost prebirth size. 
  • Kegel exercises can help strengthen pelvic floor muscles and restore vaginal tone. 
  • The inner labia may darken due to hormonal changes after age 29. As estrogen levels in the body decrease, the vaginal walls become thinner and drier. 
  • Moisturizers or creams may help combat vaginal dryness and lubricants may help with intercourse [16].
  • During menopause, the vulva may appear shrunken; vaginal atrophy is a common problem for many women. 
  • Atrophy may occur in the urethra and can lead to urine leakage, overactive bladder, and urinary incontinence [17].
  • Low estrogen may change the acidity in the vagina and may increase the risk of infection due to bacterial overgrowth. It can also impact the urinary tract [16].

 

Although CFReSHC patient-partners stated they experienced vaginal dryness, it is unclear if this occurs more frequently amongst the CF female population or why [18].

Peer to Peer Advice

  • Your vagina is self-cleaning. Use unscented and pH balanced soaps and avoid douching, baby powder and perfumed lotions to maintain optimal vaginal health.
  • Wearing cotton panties (no thongs) and avoiding tight clothes might help reduce yeast infections.
  • Boric Acid suppository (not used during pregnancy) is an OTC remedy for bacterial vaginosis.
  • Do not douche as it is not healthy. 
  • Avoid shaving/removing pubic hair. Pubic hair was put there to protect your genitalia from friction and infection 
  • Using cool packs may help with vaginal pain.
  • Rinse the vulva with water after peeing to help lower pain and irritation. 
  • Pat the vulva dry instead of rubbing it dry. The skin of your vulva is ultra sensitive, and it’s easily irritated by products with artificial additives (as many fragrant soaps, body washes, and moisturizers contain). 
  • Switch to cotton or organic menstrual pads to lessen the chance of allergy and irritation and keep pH balance in the vagina.

Results from the CFReSHC Snap Poll

A CFReSHC Snap poll (n=80) on the topic of vaginal health allowed respondents to identify and rank which research topics they found important: 

  • How does CFRD play a role in chronic yeast infections? (55.6%)
  • How much do our cervical mucus issues play a role in our vaginal health? (54.2%)
  • Do women with CF have more vaginal discharge? Different kinds of vaginal discharge? (50%)

At what age do we start to see vaginal changes in women with CF? (44.4%) [11].


Resource Links

For further information: see the National Vulvodynia Association and The latest news, information and studies on vulvodynia.

Works Cited

  1. Kazmerski TM, Sawicki GS, Miller E, et al. Sexual and reproductive health behaviors and experiences reported by young women with cystic fibrosis. Journal of Cystic Fibrosis. 2018;17(1):57-63. http://dx.doi.org/10.1016/j.jcf.2017.07.017. doi: 10.1016/j.jcf.2017.07.017.
  2. Longo L, Speri A, Sartori G, Doro R. Preliminary results of a nurse-led study cystic fibrosis center of Veneto, Verona, Italy. Abstract. J Cystic Fibrosis. 2002;1:S81–S180. 
  3. Rousset Jablonski C, Reynaud Q, Perceval M, et al. Contraceptive practices and cervical screening in women with cystic fibrosis. Human Reproduction. 2015;30(11):2547-2551. https://www.ncbi.nlm.nih.gov/pubmed/26345688. doi: 10.1093/humrep/dev217.
  4. Cystic Fibrosis Foundation. How does CF affect the female reproductive system. https://www.cff.org/Life-With-CF/Transitions/Reproductive-Health-and-Fertility/How-Does-CF-Affect-the-Female-Reproductive-System.
  5. Chambers R, Chambers R, Lucht A, et al. Prevalence and impact of pelvic floor dysfunction in an adult cystic fibrosis population: A questionnaire survey. Int Urogynecol J. 2017;28(4):591-604. https://www.ncbi.nlm.nih.gov/pubmed/27738735. doi: 10.1007/s00192-016-3152-z.
  6. Rousset Jablonski C, Reynaud Q, Perceval M, et al. Contraceptive practices and cervical screening in women with cystic fibrosis. Human Reproduction. 2015;30(11):2547-2551. https://www.ncbi.nlm.nih.gov/pubmed/26345688. doi: 10.1093/humrep/dev217.
  7. National Vulvodynia Association. The latest news, information and studies on vulvodynia. https://www.nva.org.
  8. Nelson A, De Soyza A, Perry JD, Sutcliffe IC, Cummings SP. Polymicrobial challenges to koch’s postulates: Ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes. Innate immunity (London, England). 2012;18(5):774-783. https://search.datacite.org/works/10.1177/1753425912439910. doi: 10.1177/1753425912439910.
  9. Baldwin S. CFReSHC patient task force presentation on vaginal health. 2.12.2020.
  10. Baldwin SB. CFReSHC patient task force presentation on vaginal health. 2.23.2019.
  11. Chin‐Hong PV. Time to take on HPV in the Transplant clinic — warts and all. American Journal of Transplantation. 2019;19(1):11-12. https://onlinelibrary.wiley.com/doi/abs/10.1111/ajt.15108. doi: 10.1111/ajt.15108.
  12. Cyganek A, Pietrzak B, Wielgoś M, Grzechocińska B. Menopause in women with chronic immunosuppressive treatment – how to help those patients. Przegla̜d menopauzalny. 2016;15(1):1-5. https://www.ncbi.nlm.nih.gov/pubmed/27095951. doi: 10.5114/pm.2016.58765.
  13. Sauerbrei A. Herpes genitalis: Diagnosis, treatment and prevention. Geburtshilfe und Frauenheilkunde. 2016;76(12):1310-1317. http://dx.doi.org/10.1055/s-0042-116494. doi: 10.1055/s-0042-116494.
  14. CF Reproductive and Sexual Health Collaborative. CFReSHC snap poll of vaginal health treatment options. 5.16.2020.
  15. Irving G, Miller D, Robinson A, Reynolds S, Copas AJ. Psychological factors associated with recurrent vaginal candidiasis: A preliminary study. Sexually Transmitted Infections. 1998;74(5):334-338. http://dx.doi.org/10.1136/sti.74.5.334. doi: 10.1136/sti.74.5.334.
  16. McDermott A. What you need to know about vaginal health at every age. Healthline. 2016.
  17. Johannesson M, Carlson M, Brucefors AB, Hjelte L. Cystic fibrosis through a female perspective: Psychosocial issues and information concerning puberty and motherhood. Patient Education and Counseling. 1998;34(2):115-123. 

http://dx.doi.org/10.1016/S0738-3991(97)00087-6. doi: 10.1016/S0738-3991(97)00087-6.

  1. CF Reproductive and Sexual Health Collaborative. CFReSHC patient task force meeting on vaginal health. 2.12.2020.

Free Printable PDF Download

Want a free printable PDF download of this section for your use in clinic? Just give us your name and email address below to get your download link. This will not add you to our email list.

error: Content is protected !!